Elanco's Q3 pet health revenue rises 14% to US$608 million as it lifts 2026 outlook

EN
eFeedLink Newsdesk
7 Nov 2026
Elanco's Q3 pet health revenue rises 14% to US$608 million as it lifts 2026 outlook

The US animal health company raised its full-year revenue and earnings guidance on gains for its Zenrelia and Credelio Quattro pet products.

Share:LinkedInX